lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p/HDGF.

Zou, Min-Jun; Cheng, Xiao-Rong; Liu, Rui-Feng

Zou, Min-Jun; Cheng, Xiao-Rong; Liu, Rui-Feng.

Affiliation

Zou MJ; Department of Pharmacy, The People's Hospital of Zhongshan City, Zhongshan, Guangdong Province, China.
Cheng XR; Department of Pharmacy, The People's Hospital of Zhongshan City, Zhongshan, Guangdong Province, China.
Liu RF; Department of Pharmacy, The People's Hospital of Zhongshan City, Zhongshan, Guangdong Province, China.

J Obstet Gynaecol Res ; 48(7): 1836-1847, 2022 Jul.

Article in En | MEDLINE | ID: mdl-35388952

Subject(s)

MicroRNAs; RNA, Long Noncoding; Uterine Cervical Neoplasms; Animals; Cell Line, Tumor; Cell Proliferation/genetics; Deoxycytidine/analogs & derivatives; Discs Large Homolog 1 Protein/genetics; Discs Large Homolog 1 Protein/metabolism; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Mice; Mice, Nude; MicroRNAs/genetics; MicroRNAs/metabolism; RNA, Long Noncoding/genetics; Uterine Cervical Neoplasms/drug therapy; Uterine Cervical Neoplasms/genetics; Uterine Cervical Neoplasms/metabolism; Gemcitabine

Key words

DLG1-AS1; HDGF; cervical cancer; gemcitabine; miR-16-5p

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / MicroRNAs / RNA, Long Noncoding Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Obstet Gynaecol Res Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google